The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), Amphastar Pharmaceuticals's share price is $40.70. Amphastar Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was $13.30. Hence, Amphastar Pharmaceuticals's PB Ratio of today is 3.06.
Good Sign:
Amphastar Pharmaceuticals Inc stock PB Ratio (=3.08) is close to 1-year low of 2.98
The historical rank and industry rank for Amphastar Pharmaceuticals's PB Ratio or its related term are showing as below:
AMPH'
s PB Ratio Range Over the Past 10 Years
Min: 1.37 Med: 2.46 Max: 5.2
Current: 3.06
During the past 13 years, Amphastar Pharmaceuticals's highest PB Ratio was 5.20. The lowest was 1.37. And the median was 2.46.
AMPH's PB Ratio is ranked worse than 69.85% of 962
companies
in the Drug Manufacturers industry
Industry Median: 1.945
vs AMPH: 3.06
During the past 12 months, Amphastar Pharmaceuticals's average Book Value Per Share Growth Rate was 21.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 16.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 12.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 7.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Amphastar Pharmaceuticals was 16.20% per year. The lowest was -39.30% per year. And the median was 5.80% per year.
Back to Basics: PB Ratio
Amphastar Pharmaceuticals PB Ratio Historical Data
The historical data trend for Amphastar Pharmaceuticals's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Amphastar Pharmaceuticals's PB Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amphastar Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where Amphastar Pharmaceuticals's PB Ratio falls into.
Amphastar Pharmaceuticals PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Amphastar Pharmaceuticals's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Amphastar Pharmaceuticals (NAS:AMPH) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Amphastar Pharmaceuticals PB Ratio Related Terms
Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Business Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMPH has been successfully added to your 